Michael Manning is an accomplished cardiothoracic anesthesiologist who has been a prolific author and pioneer in numerous areas of medical research. Over the past two decades, he has published extensively in peer-reviewed journals on topics ranging from the basic science behind neuotoxicity and neuroprotection to the clinically relevant topics of morbid obesity, angiotensin, atherosclerosis, aortic aneurysms, and coronary artery bypass surgery.
Dr. Manning received his MD/PhD from University of Kentucky. While there, he was the recipient the Gill Heart Student award, the American Heart Association New Investigator Award, the Merlin Bumpus Award, and the Saha Award for Excellence in Cardiovascular Research and Education. He also served as a member of the Board of Directors for the University of Kentucky College of Medicine.
After completing a fellowship in cardiovascular anesthesiology at Duke University, Dr. Manning joined the faculty there to provide clinical care and perform research in cardiovascular anesthesia. He has been the recipient of the Dick Smith Award for Clinical Research and been awarded over $230,000 in research funding, most recently for his seminal work on atrial fibrillation following cardiopulmonary bypass.
Dr. Manning is a Reviewer for the popular journal Seminars in Cardiothoracic and Vascular Anesthesia. He also serves on two AHA Councils: (1) Cardiovascular Surgery and Anesthesia and (2) Atherosclerosis, Thrombosis, and Vascular Biology. In addition, he is been an active lecturer for and mentor to a generation of medical students, residents, fellows, and fellow faculty.
Dr. Manning’s current areas of research interest are divided into two camps: (1) Basic-translational (Novel cardio-protective therapies for cardiac surgery and transplantation, animal models of myocardial ischemia-reperfusion injury and vein graft disease, systems biology approaches to perioperative cardiovascular injury and adaptation, functional genomics of myocardial ischemia-reperfusion injury and vein graft disease, genetic and genome-wide association studies in perioperative medicine) and (2) Clinical (biomarker discovery and validation for perioperative and long-term adverse cardiovascular outcomes following cardiac surgery, novel risk predictors of perioperative organ dysfunction, perioperative glycemic control and metabolic optimization).
Dr. Manning is married with two children. Anesthesiology Consultants is fortunate to have him lend his considerable experience and expertise to help candidates learn medicine at the level of a Perioperative Consultant.
